Navigation Links
ASBMB honors Bill and Melinda Gates with Schachman Award
Date:7/29/2008

The American Society for Biochemistry and Molecular Biology (ASBMB) has selected Bill and Melinda Gates as recipients of the 2009 Howard K. Schachman Public Service Award, the society's highest nonscientific honor.

The Gates' are being recognized for their outstanding commitment in supporting public health over the past several years, not only in the United States but around the world, through the Bill & Melinda Gates Foundation. The Foundation, established in 2000 through the merger of the William H. Gates Foundation and Gates Learning Foundation, has been a leader in promoting social, economic, and health equality around the globe.

"Through Bill and Melinda's exemplary efforts, more than $9 billion in grants has been made available in the Global Health Program of the Foundation to help develop vaccines, drugs, and other health solutions to some of the deadliest, and unfortunately most neglected, diseases in the world," said Gregory Petsko, professor of Chemistry and Biochemistry at Brandeis University and president of ASBMB. "We hope that this award will show in a small way that ASBMB is extremely grateful and appreciative of their efforts, their humanity and their incredible generosity."

The Schachman Award, established by the ASBMB in 2001 and given annually, recognizes dedication to public service in support of biomedical science. The award is named for Howard K. Schachman, who served as chairman of ASBMB's Public Affairs Advisory Committee for more than ten years (1989 - 2000) and made numerous contributions to biomedical research policy in both governmental and nongovernmental capacities.

The award consists of a permanent keepsake, a $5,000 honorarium, and an opportunity to deliver a lecture at the Society's annual meeting in New Orleans on April 18-22, 2009. Past recipients of this award include U.S. Representative Michael N. Castle (2008); Research!America (2007); the Honorable Sherwood Boehlert (2006), U.S. S
'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award
2. American Red Cross Honors Blood Collection Professionals During Blood Collectors Week 2007
3. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
4. Eight Michigan HMOs, Two Providers, Take Top Honors for Quality Health Care
5. Nobel Honors 3 Former March of Dimes Prize Recipients
6. Research!America Honors Univ. of Chicago Economists for Study Showing Economic Impact of HIV/AIDS Drug Development
7. Hazelden Honors Stephen I. Sadove, Chairman and CEO of Saks Fifth Avenue at its New York Awards Dinner to Benefit Youth and Families
8. GNC Honors Herb Day Tomorrow (and All Month Long)
9. THA Honors Nine Legislators for Contributions to Health Care
10. Association Honors Health Care Leaders in Midland and Troy
11. American Cancer Society Honors Outstanding Contributions to Fight Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Vivakor Announces New Acquisition Strategy 2AMT Provides Business Update for the Third Quarter 2009 14895 1AMT Provides Business Update for the Third Quarter 2009 14895 2AMT Provides Business Update for the Third Quarter 2009 14895 3AMT Provides Business Update for the Third Quarter 2009 14895 4Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 1Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 2Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML 28Mini Laboratory 29 Instrument For Point of Care Testing at MEDICA 2009 In Du 6362 3Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 1Netech Corporation Announces the Release of IPA 2000 Infusion Pump Analyzer for Fast and Accurate Testing of All Infusion Pumps 14891 2
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 2Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 3Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 4